Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Marit van Gils and Philip Brouwer.
Marit van Gils
Connection Strength
1.465
Philip Brouwer
  1. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science. 2020 08 07; 369(6504):643-650.
    View in: PubMed
    Score: 0.887
  2. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection. Cell. 2021 03 04; 184(5):1188-1200.e19.
    View in: PubMed
    Score: 0.232
  3. Human Milk from Previously COVID-19-Infected Mothers: The Effect of Pasteurization on Specific Antibodies and Neutralization Capacity. Nutrients. 2021 May 13; 13(5).
    View in: PubMed
    Score: 0.059
  4. High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages. Sci Transl Med. 2021 06 02; 13(596).
    View in: PubMed
    Score: 0.059
  5. Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity. Science. 2021 02 26; 371(6532).
    View in: PubMed
    Score: 0.058
  6. Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity. Immunity. 2020 12 15; 53(6):1272-1280.e5.
    View in: PubMed
    Score: 0.057
  7. An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain. Cell Rep. 2020 10 20; 33(3):108274.
    View in: PubMed
    Score: 0.057
  8. Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings. PLoS Pathog. 2020 09; 16(9):e1008817.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.